[10-Q] Magnera Corporation Quarterly Earnings Report
Filing Impact
Filing Sentiment
Form Type
10-Q
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
|
|
FORM 10-Q
|
|
| | Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the quarterly period ended June 28, 2025
or
| | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the transition period from to
|
|
(Address of principal executive offices)
(866 ) 744-7380
(Registrant's telephone number, including area code)
| Commission file number | Exact name of registrant as specified in its charter | IRS Employer Identification No. | State or other jurisdiction of incorporation or organization | |||
| | | | |
Former name or former address, if changed since last report
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| | | |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for at the past 90 days. Yes ☒ No ☐.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐.
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a small reporting company or emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large Accelerated Filer | ☐ | | ☒ | Non-accelerated filer | ☐ | Smaller reporting company | | Emerging growth company | |
| If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ | ||||||||
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No ☒ .
Common Stock outstanding on August 6, 2025 totaled 35.6 million shares.
|
|
CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
Information included or incorporated by reference in Magnera Corporation’s filings with the U.S. Securities and Exchange Commission (the “SEC”) and press releases or other public statements contains or may contain “forward-looking” statements within the meaning of the federal securities laws and are presented pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such “forward-looking” statements include, but are not limited to, statements with respect to our financial condition, results of operations and business, our expectations or beliefs concerning future events, including future financial and operating results, objectives, expectations and intentions, and other statements that are not historical facts. These statements contain words such as “believes,” “expects,” “may,” “will,” “should,” “would,” “could,” “seeks,” “approximately,” “intends,” “plans,” “estimates,” “projects,” “outlook,” “anticipates” or “looking forward” or similar expressions that relate to our strategy, plans, intentions, or expectations. All statements we make relating to our estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates, and financial results or to our expectations regarding future industry trends are forward-looking statements. In addition, we, through our senior management, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments. These forward-looking statements are based upon the current beliefs and expectations of the management and are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially from those that we expected.
These risks and other factors are discussed in various periodic reports filed with the Securities and Exchange Commission (the “SEC”), including in our recent Form 8-K/A filed on January 31, 2025. All forward-looking statements are made only as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.
Form 10-Q
Magnera Corporation
Form 10-Q Index
For the Quarterly Period Ended June 28, 2025
|
Part I - Financial Information
|
Page
|
||
|
Item 1
|
Financial Statements
|
2
|
|
|
Consolidated and Combined Statements of Operations and Consolidated and Combined Statements of Comprehensive Income (Loss)
|
2
|
||
|
Consolidated and Combined Balance Sheets
|
3
|
||
|
Consolidated and Combined Statements of Cash Flows
|
4
|
||
|
Consolidated and Combined Statements of Changes in Stockholders' Equity
|
5
|
||
|
Notes to Consolidated and Combined Financial Statements
|
6
|
||
|
Item 2
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
13
|
|
|
Item 3
|
Quantitative and Qualitative Disclosures About Market Risks
|
17
|
|
|
Item 4
|
Controls and Procedures
|
17
|
|
|
Part II – Other Information
|
18
|
||
|
Item 1
|
Legal Proceedings
|
18
|
|
|
Item 1A
|
Risk Factors
|
18
|
|
|
Item 6
|
Exhibits
|
19
|
|
|
Signature
|
20
|
||
Form 10-Q
Part I – Financial Information
Item 1 – Financial Statements
Magnera Corporation
Consolidated and Combined Statements of Operations
(Unaudited)
| Quarterly Period Ended | Three Quarterly Periods Ended | ||||||||||||||
| (in millions of dollars, except per share amounts) | June 28, 2025 | June 29, 2024 | June 28, 2025 | June 29, 2024 | |||||||||||
| Net sales | $ | $ | $ | $ | |||||||||||
| Costs and expenses: | |||||||||||||||
| Cost of goods sold | |||||||||||||||
| Selling, general and administrative | |||||||||||||||
| Amortization of intangibles | |||||||||||||||
| Transaction and other activities | |||||||||||||||
| Corporate expense allocation | |||||||||||||||
| Operating income (loss) | ( | ) | |||||||||||||
| Other expense (income), net | ( | ) | |||||||||||||
| Interest expense | |||||||||||||||
| Income (loss) before income taxes | ( | ) | ( | ) | |||||||||||
| Income tax benefit | ( | ) | ( | ) | ( | ) | ( | ) | |||||||
| Net income (loss) | $ | ( | ) | $ | $ | ( | ) | $ | |||||||
| Net income (loss) per share: | |||||||||||||||
| Basic and Diluted | ( | ) | ( | ) | |||||||||||
Consolidated and Combined Statements of Comprehensive Income (Loss)
(Unaudited)
| Quarterly Period Ended | Three Quarterly Periods Ended | |||||||||||||||
| (in millions of dollars) | June 28, 2025 | June 29, 2024 | June 28, 2025 | June 29, 2024 | ||||||||||||
| Net income (loss) | $ | ( | ) | $ | $ | ( | ) | $ | ||||||||
| Other comprehensive income, net of tax: | ||||||||||||||||
| Currency translation gain (loss) | ( | ) | ( | ) | ||||||||||||
| Other comprehensive income (loss) | ( | ) | ( | ) | ||||||||||||
| Comprehensive income (loss) | $ | $ | ( | ) | $ | ( | ) | $ | ||||||||
See notes to consolidated and combined financial statements.
- 2 -
Magnera Corporation
Consolidated and Combined Balance Sheets
| (in millions of dollars) | June 28, 2025 | September 28, 2024 | ||||||
| (Unaudited) | ||||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | $ | ||||||
| Accounts receivable | ||||||||
| Finished goods | ||||||||
| Raw materials | ||||||||
| Prepaid expenses and other current assets | ||||||||
| Total current assets | ||||||||
| Noncurrent assets: | ||||||||
| Property, plant and equipment | ||||||||
| Goodwill and intangible assets | ||||||||
| Right-of-use assets | ||||||||
| Other assets | ||||||||
| Total assets | $ | $ | ||||||
| Liabilities and stockholders’ equity | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | $ | ||||||
| Accrued expenses | ||||||||
| Current portion of long-term debt | ||||||||
| Total current liabilities | ||||||||
| Noncurrent liabilities: | ||||||||
| Long-term debt | ||||||||
| Deferred income taxes | ||||||||
| Operating lease liabilities | ||||||||
| Other long-term liabilities | ||||||||
| Total liabilities | ||||||||
| Stockholders’ equity: | ||||||||
| Berry net investment | ||||||||
| Additional paid-in capital | ||||||||
| Retained loss | ( | ) | ||||||
| Accumulated other comprehensive loss | ( | ) | ( | ) | ||||
| Total stockholders’ equity | ||||||||
| Total liabilities and stockholders’ equity | $ | $ |
See notes to consolidated and combined financial statements.
- 3 -
Magnera Corporation
Consolidated and Combined Statements of Cash Flows
(Unaudited)
| Three Quarterly Periods Ended | |||||||
| (in millions of dollars) | June 28, 2025 | June 29, 2024 | |||||
| Cash Flows from Operating Activities: | |||||||
| Net income (loss) | $ | ( | ) | $ | |||
| Adjustments to reconcile net cash from operating activities: | |||||||
| Depreciation | |||||||
| Amortization of intangibles | |||||||
| Non-cash interest expense | |||||||
| Deferred income tax | ( | ) | |||||
| Share-based compensation expense | |||||||
| Other non-cash operating activities, net | |||||||
| Changes in working capital, net | ( | ) | ( | ) | |||
| Change in other assets and liabilities | ( | ) | ( | ) | |||
| Net cash from operating activities | |||||||
| Cash Flows from Investing Activities: | |||||||
| Additions to property, plant and equipment, net | ( | ) | ( | ) | |||
| Cash acquired from GLT acquisition | |||||||
| Settlement of net investment hedges | |||||||
| Other investing activities and other | |||||||
| Net cash from (used in) investing activities | ( | ) | |||||
| Cash Flows from Financing Activities: | |||||||
| Proceeds from long-term borrowings | |||||||
| Repayments on long-term borrowings | ( | ) | ( | ) | |||
| Transfers from (to) Berry, net | ( | ) | |||||
| Cash distribution to Berry | ( | ) | |||||
| Debt fees and other, net | ( | ) | |||||
| Net cash from (used in) financing activities | ( | ) | |||||
| Effect of currency translation on cash | ( | ) | |||||
| Net change in cash and cash equivalents | ( | ) | |||||
| Cash and cash equivalents at beginning of period | |||||||
| Cash and cash equivalents at the end of period | $ | $ | |||||
See notes to consolidated and combined financial statements.
- 4 -
Magnera Corporation
Consolidated and Combined Statements of Changes in Stockholders’ Equity
(Unaudited)
(in millions of dollars)
| Quarterly Period Ended | Berry Net Investment | Additional Paid-in Capital | Other Comprehensive Income (Loss) - Currency Translation | Retained Loss | Total Stockholders’ Equity | ||||||||||
| Balance at March 29, 2025 | $ | $ | $ | ( | ) | $ | ( | ) | $ | ||||||
| Net loss | — | — | — | ( | ) | ( | ) | ||||||||
| Other comprehensive income (loss) | — | — | — | ||||||||||||
| Share-based compensation | — | — | — | ||||||||||||
| Other | — | — | — | ||||||||||||
| Balance at June 28, 2025 | $ | $ | $ | ( | ) | $ | ( | ) | $ | ||||||
| Balance at March 30, 2024 | ( | ) | |||||||||||||
| Net income | — | — | — | ||||||||||||
| Other comprehensive income (loss) | — | — | ( | ) | — | ( | ) | ||||||||
| Transfers from parent, net | ( | ) | — | — | — | ( | ) | ||||||||
| Balance at June 29, 2024 | $ | $ | $ | ( | ) | $ | $ |
| Three Quarterly Periods Ended | Berry Net Investment | Additional Paid-in Capital | Other Comprehensive Income (Loss) - Currency Translation | Retained Loss | Total Stockholders’ Equity | ||||||||||
| Balance at September 28, 2024 | $ | $ | $ | ( | ) | $ | $ | ||||||||
| Net loss | — | — | — | ( | ) | ( | ) | ||||||||
| Other comprehensive income (loss) | — | — | — | ||||||||||||
| Transfers to Berry, net | ( | ) | — | — | — | ( | ) | ||||||||
| October net investment | — | — | — | ||||||||||||
| Distribution of Berry’s net investment | ( | ) | — | — | |||||||||||
| Acquisition of GLT | — | — | — | ||||||||||||
| Share-based compensation | — | — | — | ||||||||||||
| Other | — | — | — | ||||||||||||
| Balance at June 28, 2025 | $ | $ | $ | ( | ) | $ | ( | ) | $ | ||||||
| Balance at September 30, 2023 | $ | $ | $ | ( | ) | $ | $ | ||||||||
| Net income | — | — | — | ||||||||||||
| Other comprehensive income (loss) | — | — | ( | ) | — | ( | ) | ||||||||
| Transfers from parent, net | ( | ) | — | — | — | ( | ) | ||||||||
| Balance at June 29, 2024 | $ | $ | $ | ( | ) | $ | $ |
See notes to consolidated and combined financial statements.
- 5 -
Magnera Corporation
Notes to Consolidated Financial Statements
(Unaudited)
(tables in millions of dollars, except per share data)
1. Basis of Presentation
The pre-Transaction combined financial results of operations, financial position, and cash flows have been prepared on a carve-out basis, which include assumptions underlying the preparation that management believe are reasonable. However, the combined pre-Transaction financial information included herein may not necessarily reflect the Company’s results of operations, financial position, and cash flows had the Company been an independent stand-alone company during the periods presented.
For periods prior to the Closing Date, transactions between Berry and Treasure were reflected as a component of Berry's net investment in the Consolidated and Combined Balance Sheets and as a financing activity within the accompanying Consolidated and Combined Statements of Cash Flows. Berry's net investment on the Consolidated and Combined Balance Sheet and Consolidated and Combined Statement of Stockholders’ Equity represents the cumulative net investment by Berry in Treasure. Concurrent with the closing of the Transaction, Berry received a cash distribution and, in turn, transferred Berry’s health, hygiene and specialties global nonwovens and films business to Treasure. As a result, Berry's net investment in Treasure was reduced to zero with a corresponding adjustment to Additional Paid-in Capital.
Recently Issued Accounting Pronouncements
In 2023, the Financial Accounting Standards Board ("FASB") issued guidance with the goal of providing more information about reportable segments, including disaggregated expense information. The Company will adopt all required disclosures requirements in fiscal 2025.
In 2023, the FASB issued guidance with the goal of providing more information in the income tax reconciliation table and regarding income taxes paid. This ASU is effective for fiscal years beginning after December 15,
2024, may be applied prospectively or retrospectively, and allows for early
adoption. The Company is currently evaluating the impact of adopting this guidance.
In 2024, the FASB issued guidance with the goal of providing more expense information for certain categories of expenses that are included in line items on the face of the statements of earnings. This ASU is effective for fiscal years beginning after December 15, 2026
and for interim periods beginning after December 15, 2027, and may be adopted
on a prospective or retrospective basis, and allows for early adoption. The Company is currently evaluating the impact of adopting this guidance.
2. Revenue and Accounts Receivable
- 6 -
The Company records current expected credit losses based on a variety of factors including historical loss experience and current customer financial condition. The changes to our current expected credit losses, write-off activity, and recoveries were not material for any of the periods presented.
The Company has entered into various factoring agreements, primarily customer-based supply chain financing programs, to sell certain receivables to third-party financial institutions. These agreements result in true sales of the transferred receivables, which occur when receivables are transferred without recourse to the Company, are reflected as a reduction of trade receivables, net on the consolidated and combined balance sheets and the proceeds are included in the cash flows from operating activities in the consolidated and combined statements of cash flows.
3. Acquisition
Glatfelter
The Transaction combined GLT’s sustainable solutions and product portfolio with Treasure’s proprietary technologies and global scale. The Company is now a global leader in growing markets while serving some of the world’s largest brand owners. The results of GLT have been included in the consolidated results of the Company since the Closing Date.
The GLT acquisition has been accounted for under the purchase method of accounting. Under this method, the assets acquired and liabilities assumed have been recorded based on estimated fair values as of the Closing Date. Certain assets, including inventory, intangibles, and property, plant, and equipment included in the purchase price allocation have been estimated based on the current valuation. The Company's valuation analysis over the acquired business will be finalized during the fourth quarter. The Company has recognized goodwill on this Transaction primarily as a result of expected cost synergies and expects goodwill not to be deductible for tax purposes.
The following table summarizes the purchase price allocation, which is preliminary and subject to change within one year of the Closing Date:
| Fair value of GLT common stock concurrent with closing | $ | ||
| Identifiable assets acquired and liabilities assumed | |||
| Cash | |||
| Working capital(a) | |||
| Property, plant and equipment | |||
| Identifiable intangible assets | |||
| Other assets | |||
| Other long-term liabilities | ( | ) | |
| Debt | ( | ) | |
| Goodwill(b) | |||
| Total consideration | $ |
(a) Includes a $12 million step up of inventory to fair value
(b) Recorded in Americas segment
When including GLT results for the periods prior to the Closing Date, unaudited pro forma net sales and net loss were $885 million and $20 million, respectively for the quarterly period ended June 29, 2024, $2,477 million and $131 million, respectively, for the three quarterly periods ended June 28, 2025, and $2,610 million and $80 million, respectively, for the three quarterly periods ended June 29, 2024. The unaudited pro forma net sales and net income figures assume that the Transaction was consummated as of the beginning of the relevant period.
- 7 -
4. Transaction and Other Activities
The table below sets forth the significant components of the Transaction and other activities, including supply chain financings activity charges recognized for the periods presented, by reportable segment:
| Quarterly Period Ended | Three Quarterly Periods Ended | ||||||||||||||
| June 28, 2025 | June 29, 2024 | June 28, 2025 | June 29, 2024 | ||||||||||||
| Americas | $ | $ | $ | $ | |||||||||||
| Rest of World | |||||||||||||||
| Consolidated | $ | $ | $ | $ | |||||||||||
The table below sets forth the activity with respect to the Transaction and other activities accrual at June 28, 2025:
| Employee Severance | Transaction | Non-Cash | Other | ||||||||||||||||
| and Benefits (a) | Activities (b) | Charges | Activities | Total | |||||||||||||||
| Balance at September 28, 2024 | $ | $ | $ | $ | |||||||||||||||
| Charges | |||||||||||||||||||
| Non-cash items | ( | ) | ( | ) | |||||||||||||||
| Cash payments | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||
| Balance at June 28, 2025 | $ | $ | $ | $ | $ |
(a) Restructuring activities
(b) Includes $19 million of Transaction related compensation
5. Leases
The Company leases certain manufacturing facilities, warehouses, office space, manufacturing equipment, office equipment, and automobiles.
Supplemental lease information is as follows:
| Leases | Classification | June 28, 2025 | September 28, 2024 | |||||
| Operating leases: | ||||||||
| Operating lease right-of-use assets | $ | $ | ||||||
| Current operating lease liabilities | ||||||||
| Noncurrent operating lease liabilities | ||||||||
| Finance leases: | ||||||||
| Finance lease right-of-use assets | $ | $ |
- 8 -
6. Long-Term Debt
Long-term debt consists of the following:
| Facility | Maturity Date | June 28, 2025 | September 28, 2024 | |||||
| Revolving Credit Facility | $ | $ | ||||||
| Term Loan | ||||||||
| Debt discounts, deferred fees and other | ( | ) | ||||||
| Total long-term debt | ||||||||
| Current portion of long-term debt | ( | ) | ||||||
| Long-term debt, less current portion | $ | $ |
As part of the Transaction, the Company consummated a $785 million Term Loan due 2031 (the “Term Loan”), an $800 million issuance of 7.25 % First Priority Senior Secured Notes due 2031 (the “7.25 % Notes”), and a $350 million revolving credit facility (the “Revolving Credit Facility”). The proceeds from the Term Loan and 7.25 % Notes were used to retire a portion of GLT outstanding debt and fund a cash distribution to Berry.
Despite not having financial maintenance covenants on our Term Loan and secured notes, these agreements do contain certain negative covenants. The failure to comply with these negative covenants could restrict our ability to incur additional indebtedness, effect acquisitions, enter into certain significant business combinations, make distributions or redeem indebtedness. The current portion of long-term debt consists of quarterly principal payments on the term loan due within one year. We are in compliance with all covenants as of June 28, 2025.
Debt discounts, deferred financing fees and the purchase price adjustment related to the retained GLT 4.75 % First Priority Senior Secured Notes are presented net of Long-term debt, less the current portion on the Consolidated and Combined Balance Sheets and are amortized to Interest expense on the Consolidated and Combined Statements of Operations through maturity.
7. Financial Instruments and Fair Value Measurements
In the normal course of business, the Company is exposed to certain risks arising from business operations and economic factors. The Company may use derivative financial instruments to help manage market risk and reduce the exposure to fluctuations in foreign currencies. These financial instruments are not used for trading or other speculative purposes.
Cross-Currency Swaps
The Company is party to certain cross-currency swaps to hedge a portion of our foreign currency risk. During fiscal 2025, the Company received net proceeds of $22 million related to the settlement of existing cross-currency rate swaps, with the offset being recorded in Accumulated other comprehensive loss. Following the settlement, the Company entered into a €250 million and a €425 million cross-currency swap, maturing November 2027 and November 2029 respectively. The swaps are designated as a hedge of the Company’s foreign currency investment in foreign subsidiaries. When valuing cross-currency swaps the Company utilizes Level 2 inputs (substantially observable).
- 9 -
The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized. Balances on a gross basis are as follows:
| Derivative Instruments | Hedge Designation | Balance Sheet Location | June 28, 2025 | September 28, 2024 | |||||||
| Cross-currency swaps | Designated | Other long-term liabilities | $ | ( | ) | $ |
The effect of the Company’s derivative instruments on the Consolidated and Combined Statements of Operations is as follows:
| Quarterly Period Ended | Three Quarterly Periods Ended | ||||||||||||||||
| Derivative Instruments | Statements of Income Location | June 28, 2025 | June 29, 2024 | June 28, 2025 | June 29, 2024 | ||||||||||||
| Cross-currency swaps | Interest expense | $ | $ | $ | $ | ||||||||||||
Non-recurring Fair Value Measurements
The Company has certain assets that are measured at fair value on a non-recurring basis when impairment indicators are present or when the Company completes an acquisition. The Company adjusts certain long-lived assets to fair value only when the carrying values exceed the fair values. The categorization of the framework used to value the assets is considered Level 3, due to the subjective nature of the unobservable inputs used to determine the fair value. These assets that are subject to our impairment analysis primarily include our definite lived and indefinite lived intangible assets, including Goodwill and our Property, plant and equipment. The Company reviews Goodwill and other indefinite lived assets for impairment as of the first day of the fourth fiscal quarter each year and more frequently if impairment indicators exist. As a result of the fiscal 2024 assessment, the Company recorded an impairment charge of $172 million. No impairment indicators were identified in the current quarter.
Included in the following tables are the major categories of assets and their current carrying values, along with the impairment loss recognized on the fair value measurement for the period then ended:
| June 28, 2025 | |||||||||||||||||||
| Level 1 | Level 2 | Level 3 | Total | Impairment | |||||||||||||||
| Indefinite-lived trademarks | $ | — | $ | — | $ | $ | $ | — | |||||||||||
| Goodwill | |||||||||||||||||||
| Definite lived intangible assets | |||||||||||||||||||
| Property, plant, and equipment | |||||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||||
| September 28, 2024 | |||||||||||||||||||
| Level 1 | Level 2 | Level 3 | Total | Impairment | |||||||||||||||
| Indefinite-lived trademarks | $ | — | $ | — | $ | $ | $ | — | |||||||||||
| Goodwill | ( | ) | |||||||||||||||||
| Definite lived intangible assets | ( | ) | |||||||||||||||||
| Property, plant, and equipment | |||||||||||||||||||
| Total | $ | $ | $ | $ | $ | ( | ) | ||||||||||||
The Company’s financial instruments consist primarily of cash and cash equivalents, long-term debt, and cross-currency swap agreements. The book value of our marketable long-term indebtedness exceeded fair value by $104 million as of June 28, 2025. The Company’s long-term debt fair values were determined using Level 2 inputs (substantially observable).
8. Income Taxes
The YTD effective income tax rate was unfavorably impacted by the jurisdictional mix of pre-tax results among the Company and its subsidiaries and losses, which generate no tax benefit in domestic and certain foreign jurisdictions.
On July 4, 2025, the One Big Beautiful Bill Act (the “Act”) was enacted. The Act provides for several corporate tax changes including, but not limited to, restoring full expensing of domestic research and development costs, restoring immediate deductibility of certain capital expenditures, and changes in the computations of U.S. taxation on international earnings. We will continue to evaluate the impact this tax legislation may have on our business.
- 10 -
9. Segment and Geographic Data
The Company’s operations are organized into two
Selected information by reportable segment is presented in the following tables:
| Quarterly Period Ended | Three Quarterly Periods Ended | ||||||||||||||
| June 28, 2025 | June 29, 2024 | June 28, 2025 | June 29, 2024 | ||||||||||||
| Net Sales | |||||||||||||||
| Americas | $ | $ | $ | $ | |||||||||||
| Rest of World | |||||||||||||||
| Total net sales | $ | $ | $ | $ | |||||||||||
| Operating income (loss) | |||||||||||||||
| Americas | $ | $ | $ | $ | |||||||||||
| Rest of World | ( | ) | ( | ) | |||||||||||
| Total operating income (loss) | $ | $ | $ | ( | ) | $ | |||||||||
| Depreciation and amortization | |||||||||||||||
| Americas | $ | $ | $ | $ | |||||||||||
| Rest of World | |||||||||||||||
| Total depreciation and amortization | $ | $ | $ | $ | |||||||||||
Selected information by geographical region is presented in the following table:
| Quarterly Period Ended | Three Quarterly Periods Ended | ||||||||||||||
| June 28, 2025 | June 29, 2024 | June 28, 2025 | June 29, 2024 | ||||||||||||
| Net Sales | |||||||||||||||
| United States and Canada | $ | $ | $ | $ | |||||||||||
| Latin America | |||||||||||||||
| Rest of World | |||||||||||||||
| Total net sales | $ | $ | $ | $ | |||||||||||
Selected information by category is presented in the following tables:
| Quarterly Period Ended | Three Quarterly Periods Ended | ||||||||||||||
| June 28, 2025 | June 29, 2024 | June 28, 2025 | June 29, 2024 | ||||||||||||
| Net Sales | |||||||||||||||
| Personal Care | % | % | % | % | |||||||||||
| Consumer Solutions | % | % | % | % | |||||||||||
- 11 -
10. Contingencies and Commitments
Litigation
The Company is party to various legal proceedings involving routine claims which are incidental to its business. Although the Company’s legal and financial liability with respect to such proceedings cannot be estimated with certainty, the Company believes that any ultimate liability would not be material to its consolidated and combined financial position, results of operations or cash flows.
Environmental Claims
Over the next 30 years, we are primarily responsible for the reimbursement of government oversight costs associated with certain environmental claims regarding the Fox River located in Neenah, Wisconsin. At June 28, 2025, the outstanding balance of the environmental liability and corresponding escrow asset was $18 million and $9 million, respectively.
Tax Claims
As part of a previous acquisition, the Company acquired a liability related to certain tax claims treated as a deferred purchase price (the “Deferred Consideration”). The Deferred Consideration accretes at a rate of 9.5 % per annum compounded daily, which shall be paid to the selling stockholders of the previous acquisition to the extent certain existing and potential tax claims are resolved. At June 28, 2025 and June 29, 2024, the outstanding balance of the Deferred Consideration was $56 million and $51 million, respectively. If the Company incurs actual tax liability with respect to the tax claims, the amount of the Deferred Consideration owed to the selling stockholders will be reduced by the amount of such actual tax liability. The Company will be responsible for any actual tax liability in excess of the Deferred Consideration. The Deferred Consideration is reflected on the consolidated and combined balance sheets in Other long-term liabilities as the settlement of existing and potential claims is expected to be greater than one year.
11. Basic and Diluted Net Income (Loss) Per Share
Basic net income or earnings per share ("EPS") is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for common stock equivalents.
The following tables provide a reconciliation of the numerator and denominator of the basic and diluted EPS calculations:
|
Quarterly Period Ended
|
Three Quarterly Periods Ended
|
||||||||||||||
|
(in millions)
|
June 28, 2025
|
June 29, 2024
|
June 28, 2025
|
June 29, 2024
| |||||||||||
|
Numerator
|
|||||||||||||||
|
Consolidated net income (loss)
|
$ | ( | ) | $ | $ | ( | ) | $ | |||||||
|
Denominator
|
|||||||||||||||
|
Weighted average common shares outstanding - basic and dilutive
|
|||||||||||||||
While there were no shares outstanding in prior periods, an allocation of 90 % of the shares as of the completion of the Transaction have been provided for comparability purposes. Shares excluded from the current period calculation, as the effect of their conversion into shares of our common stock would be antidilutive were 1.1
12. Corporate Expense Allocation
Based on management estimates, $3 million and $17 million of general corporate expenses including information technology, accounting, legal, human resources, and other services were allocated to Treasure periods prior to the Closing Date during the nine months ended June 28, 2025 and June 29, 2024, respectively.
- 12 -
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Executive Summary
Business. The Company’s operations are organized into two operating segments: Americas and Rest of the World. The structure is designed to align us with our customers, provide improved service, drive future growth and to facilitate synergy realization. The Americas segment consists of sites in North America and South America that manufacture a wide range of products and components of personal care and consumer solution products and components of products including medical garments, wipes, dryer sheets, face masks, filtration, baby diapers and adult incontinence. The Rest of World segment consists of sites throughout Europe and China that manufacture a broad collection of personal care and consumer solution products and components of products including medical garments, wipes, cable wrap, filtration, baby diapers and adult incontinence.
Raw Material Trends. Our primary raw materials are polymer resin and wood-based fibers and pulps. In addition, we use other materials in various manufacturing processes. While temporary industry-wide shortages of raw materials have occurred, we have historically been able to manage the supply chain disruption by working closely with our suppliers and customers. Changes in the price of raw materials are generally passed on to customers through contractual price mechanisms over time, during contract renewals, and other means.
Outlook. The Company is affected by general economic and industrial growth, raw material availability, cost inflation, supply chain disruptions, new and changing tariffs and general industrial production. Our business has both geographic and end market diversity, which reduces the effect of any one of these factors on our overall performance. Our results are affected by our ability to pass through raw material and other cost changes, including tariffs, to our customers, improve manufacturing productivity and adapt to volume changes of our customers. During fiscal 2025, the Company announced capacity rationalizations in order to deliver future cost savings and optimize equipment utilization. In total, over the next two years, these actions are projected to cost approximately $20 million with the operations savings intended to counter general economic softness. Despite global macro-economic challenges and uncertainties attributed to continued rising inflation, changing tariff policies and general market softness, we continue to believe our underlying long-term demand fundamental in all divisions will remain strong as we focus on providing advantaged products in targeted markets. For fiscal 2025, we project post-Transaction free cash flow of $75-95 million including $75 million of capital spending. For the calculation of post-Transaction free cash flow and further information related to free cash flow as a non-GAAP financial measure, see “Liquidity and Capital Resources.”
Acquisition Strategy
As part of our growth strategy, we intend pursue additional acquisition targets. Our acquisition strategy is focused on identifying attractive assets that will support improving our long-term financial performance, enhancing our market positions, and expanding our existing and complementary product lines. We seek to obtain businesses for attractive post-synergy multiples, creating value for our stockholders from synergy realization, leveraging the acquired products across our customer base, creating new platforms for future growth, and assuming best practices from the businesses we acquire. While the expected benefits on earnings will be estimated at the commencement of each transaction, once the execution of the plan and integration occur, we may be unable to accurately estimate or track what the ultimate effects will be due to system integrations and movements of activities to multiple facilities.
Glatfelter
On November 4, 2024, the Transaction was completed with GLT. The Transaction combined GLT’s sustainable solutions and product portfolio with Treasure’s portfolio of proprietary technologies and global scale. The Company is now a global leader in growing markets while serving some of the world’s largest brand owners. The Company expects to realize annual synergies of $55 million net of incremental standalone costs. See Note 3—Acquisition.
Results of Operations
Comparison of the Quarterly Period Ended June 28, 2025 (the “Quarter”) and the Quarterly Period Ended June 29, 2024 (the “Prior Quarter”)
Business integration expenses consist of restructuring and impairment charges, acquisition/merger related costs, and other business optimization costs. Tables present dollars in millions.
- 13 -
Consolidated Overview
| Quarter | Prior Quarter | $ Change | % Change | ||||||||||||
|
Net sales
|
$ | 839 | $ | 556 | $ | 283 | 51 | % | |||||||
|
Operating income
|
13 | 17 | (4 | ) | (24 | )% |
Net sales: The net sales increase included revenue from the Transaction of $320 million which was partially offset by a $7 million decrease in selling prices and a 5% organic volume decline which was attributed to general market softness in Europe and competitive pressures from imports in South America.
Operating income (loss): The operating income decline included an $8 million unfavorable impact from increased business integration costs, a $4 million unfavorable impact from the volume decline, a $4 million increase in stock compensation expense and an unfavorable impact from price cost spread of $3 million, partially offset by the elimination of $8 million in corporate expense allocations in Prior Quarter and income from the acquired GLT business of $5 million.
Americas
| Quarter | Prior Quarter | $ Change | % Change | ||||||||||||
|
Net sales
|
$ | 473 | $ | 388 | $ | 85 | 22 | % | |||||||
|
Operating income
|
12 | 16 | (4 | ) | (25 | )% |
Net sales: The net sales increase included revenue from the Transaction of $124 million partially offset by decreased selling prices of $8 million, a $9 million unfavorable impact from foreign currency changes and a 6% organic volume decline which was primarily attributed to competitive pressures from imports in South America.
Operating income: The operating income decline included a $5 million unfavorable impact from increased business integration costs, a $3 million unfavorable impact from the volume decline, a $3 million increase in stock compensation expense and an unfavorable impact from price cost spread of $5 million, partially offset by the elimination of $6 million in corporate expense allocations in Prior Quarter and income from the acquired GLT business of $5 million.
Rest of World
| Quarter | Prior Quarter | $ Change | % Change | ||||||||||||
|
Net sales
|
$ | 366 | $ | 168 | $ | 198 | 118 | % | |||||||
|
Operating income
|
1 | 1 | — | — | % |
Net sales: The net sales increase included revenue from the Transaction of $196 million and a $7 million favorable impact from foreign currency changes, partially offset by a 3% organic volume decline which was primarily attributed to general market softness in Europe.
Operating income: The operating income decline included a $3 million unfavorable impact from increased business integration costs partially offset by the elimination of corporate expense allocations in Prior Quarter.
Interest expense: The interest expense increase is primarily attributed to debt that was incurred concurrently with the closing of the Transaction.
Changes in Comprehensive Income
The $50 million increase in comprehensive income from the Prior Quarter is attributed to a $87 million favorable change in currency translation offset by a $37 million increased net loss. Currency translation changes are primarily related to non-U.S. subsidiaries with a functional currency other than the U.S. dollar, whereby assets and liabilities are translated from the respective functional currency into U.S. dollars using period-end exchange rates. The change in currency translation in the Quarter was primarily attributed to locations utilizing the Euro and Brazilian real as their functional currency. As part of its overall risk management, the Company uses derivative instruments to reduce foreign currency exposure to translation of certain foreign operations. The Company records changes to the fair value of these instruments in Accumulated other comprehensive loss. The change in fair value of these instruments in the Quarter is primarily attributed to the change in the forward foreign exchange curves between measurement dates.
- 14 -
Comparison of the Three Quarterly Periods Ended June 28, 2025 (the “YTD”) and the Three Quarterly Periods Ended June 29, 2024 (the “Prior YTD”)
Business integration expenses consist of restructuring and impairment charges, acquisition/merger related costs, and other business optimization costs. Tables present dollars in millions.
Consolidated Overview
| YTD | Prior YTD | $ Change | % Change | ||||||||||||
|
Net sales
|
$ | 2,365 | $ | 1,633 | $ | 732 | 45 | % | |||||||
|
Operating income (loss)
|
(5 | ) | 26 | (31 | ) | (119 | )% |
Net sales: The net sales increase included revenue from the Transaction of $817 million, which was partially offset by a $42 million unfavorable impact from foreign currency changes and a 2% organic volume decline which was attributed to general market softness in Europe and competitive pressures from imports in South America.
Operating income (loss): The operating loss increase included a $12 million inventory fair value step-up charge, a $25 million unfavorable impact from increased business integration costs, a $7 million unfavorable impact from foreign currency changes and an $11 million increase in stock compensation expense partially offset by a $15 million favorable change from prior year hyperinflation in our Argentinian subsidiary and the elimination of $14 million in corporate expense allocations in Prior Year.
Americas
| YTD | Prior YTD | $ Change | % Change | ||||||||||||
|
Net sales
|
$ | 1,366 | $ | 1,111 | $ | 255 | 23 | % | |||||||
|
Operating income
|
13 | 33 | (20 | ) | (60 | )% |
Net sales: The net sales increase included revenue from the Transaction of $318 million partially offset by a $37 million unfavorable impact from foreign currency changes and a 2% organic volume decline which was primarily attributed to competitive pressures from imports in South America.
Operating income: The operating income decrease included a $23 million unfavorable impact from increased business integration costs, a $5 million inventory fair value step-up charge, a $6 million unfavorable impact from foreign currency changes, a $6 million increase in stock compensation expense and $6 million unfavorable price cost spread partially offset by a $15 million favorable change from prior year hyperinflation in our Argentinian subsidiary and the elimination of $12 million in corporate expense allocations in Prior Year.
Rest of World
| YTD | Prior YTD | $ Change | % Change | ||||||||||||
|
Net sales
|
$ | 999 | $ | 522 | $ | 477 | 91 | % | |||||||
|
Operating loss
|
(18 | ) | (7 | ) | (11 | ) | (157 | )% |
Net sales: The net sales increase included revenue from the Transaction of $499 million partially offset by a 3% organic volume decline which was primarily attributed to general market softness in Europe.
Operating loss: The operating loss increase included a $7 million inventory fair value step-up charge, losses from the acquired Glatfelter business of $6 million and a $5 million increase in stock compensation expense partially offset by a $6 million favorable impact from price cost spread.
Other expense: The increase in other expense is due to a $15 million prepayment penalty charge for retiring debt concurrently with the Transaction, $8 million of non-cash charges associated with pre-Transaction tax liabilities, and currency losses related to intercompany loans.
Interest expense: The interest expense increase is primarily attributed to debt that was incurred concurrently with the closing of the Transaction.
- 15 -
Changes in Comprehensive Income
The $121 million decline in comprehensive income from the Prior YTD is attributed to a $23 million favorable change in currency translation and a $144 million increased net loss. Currency translation changes are primarily related to non-U.S. subsidiaries with a functional currency other than the U.S. dollar whereby assets and liabilities are translated from the respective functional currency into U.S. dollars using period-end exchange rates. The change in currency translation in the Quarter was primarily attributed to locations utilizing the Euro and Brazilian real as their functional currency. As part of its overall risk management, the Company uses derivative instruments to reduce foreign currency exposure to translation of certain foreign operations. The Company records changes to the fair value of these instruments in Accumulated other comprehensive loss. The change in fair value of these instruments in the quarter is primarily attributed to the change in the forward foreign exchange curves between measurement dates.
Liquidity and Capital Resources
Senior Secured Credit Facility
We manage our global cash requirements considering (i) available funds among the many subsidiaries through which we conduct business, (ii) the geographic location of our liquidity needs, and (iii) the cost to access international cash balances. At the end of the Quarter, the Company had no outstanding balance on its asset-based revolving line of credit that matures in November 2029. The Company was in compliance with all covenants at the end of the Quarter.
Cash Flows
Net cash from operating activities decreased $24 million from the Prior YTD primarily related to a decline in net income prior to non-cash activities primarily due to costs related to the Transaction.
Net cash from investing activities increased $34 million from the Prior YTD primarily attributed to cash acquired in connection with the Transaction and settlement of net investment hedges in the YTD compared to the settlement of short-term marketable securities in Prior YTD.
Net cash from financing activities increased $39 million from Prior YTD primarily attributed to higher transfers from Berry prior to the Transaction.
Free Cash Flow
Our consolidated free cash flow for the YTD are summarized as follows:
| June 28, 2025 | |||
|
Cash flow from operating activities
|
$ | 7 | |
|
Pre-Transaction free cash flow from operating activities
(1)
|
90 | ||
|
Additions to property, plant and equipment
|
(52 | ) | |
|
Post-Transaction free cash flow
|
$ | 45 |
(1) Pre-merger cash flow includes pre-Transaction cash from operations and other cash payments burdened by the Transaction.
We use free cash flow metrics as a supplemental measure of liquidity as it assists us in assessing our ability to fund growth through generation of cash. Free cash flow metrics may be calculated differently by other companies, including other companies in our industry or peer group, limiting its usefulness on a comparative basis. Free cash flow metrics are not a financial measure presented in accordance with GAAP and should not be considered as an alternative to any other measure determined in accordance with GAAP.
Liquidity Outlook
At June 28, 2025, our cash balance was $276 million, which was primarily located outside the U.S. We believe our existing U.S. based cash and cash flow from U.S. operations, together with available borrowings under our senior secured credit facilities, will be adequate to meet our short-term and long-term liquidity needs with the exception of funds needed to cover all long-term debt obligations, which we intend to refinance prior to maturity. The Company has the ability to repatriate the cash located outside the U.S. to the extent not needed to meet operational and capital needs without significant restrictions.
- 16 -
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Interest Rate Risk
We are exposed to market risk from changes in interest rates primarily through our senior secured credit facilities and accounts receivable supply chain financing programs. Our senior secured credit facilities are comprised of (i) $781 million Term Loan and (ii) the $350 million Revolving Credit Facility with no borrowings outstanding. Borrowings under our senior secured credit facilities bear interest at a rate equal to an applicable margin plus SOFR. The applicable margin for SOFR rate borrowings under the Revolving Credit Facility ranges from 1.50% to 2.00%, and the margin for the Term Loan is 4.25% per annum. As of period end, the SOFR rate of approximately 4.39% was applicable to the Term Loan. A change of 0.25% on these floating interest rate exposures would increase our annual interest expense by approximately $2 million.
Foreign Currency Risk
As a global company, we face foreign currency risk exposure from fluctuating currency exchange rates, primarily the U.S. dollar against the Euro, British pound sterling, Brazilian real, Chinese renminbi, Canadian dollar and Mexican peso. Significant fluctuations in currency rates can have a substantial impact, either positive or negative, on our revenue, cost of sales, and operating expenses. Currency translation gains and losses are primarily related to non-U.S. subsidiaries with a functional currency other than U.S. dollars whereby assets and liabilities are translated from the respective functional currency into U.S. dollars using period-end exchange rates and impact our Comprehensive income. A 10% decline in foreign currency exchange rates would have had a $2 million unfavorable impact on our Net income for the quarterly period ended June 28, 2025. See Note 7—Financial Instruments and Fair Value Measurements.
Item 4. Controls and Procedures
(a) Evaluation of Disclosure Controls and Procedures.
Under applicable SEC regulations, management of a reporting company, with the participation of the principal executive officer and principal financial officer, must periodically evaluate the company’s “disclosure controls and procedures,” which are defined generally as controls and other procedures of a reporting company designed to ensure that information required to be disclosed by the reporting company in its periodic reports filed with the commission (such as this Form 10-Q) is recorded, processed, summarized, and reported on a timely basis.
The Company’s management, with the participation of the Chief Executive Officer and the Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of the disclosure controls and procedures as of the end of the period covered by this report. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the design and operation of our disclosure controls and procedures were effective at the reasonable assurance level as of the end of the period covered by this report.
(b) Changes in internal control over financial reporting.
As part of the Transaction’s transition services agreement, the Company will rely on Berry’s systems and processes through the integration period. In May 2025, Berry merged with Amcor plc (“Amcor”). Ramifications to the Company, specifically around ERP system controls, as a result of the Berry/Amcor merger are being assessed and we will continue to evaluate the potential impacts to the transition services provided by Berry/Amcor and closely monitor developments as they arise.
Other than in connection with the Transaction and the merger of Berry and Amcor, there were no changes in our internal control over financial reporting that occurred during the Quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
- 17 -
Part II – Other Information
Item 1. Legal Proceedings
See the discussion of legal proceedings contained in Note 10—Contingencies and Commitments to our unaudited consolidated financial statements in Part I, Item 1 of this report, which is incorporated herein by reference.
Item 1A. Risk Factors
Before investing in our securities, we recommend that investors carefully consider the risks described in our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, including our Form 8-K/A filed on January 31, 2025, and other documents filed with the SEC. Realization of any of these risks could have a material adverse effect on our business, financial condition, cash flows and results of operations. Except as follows, there have been no material changes to the risk factors included in our SEC filings.
Additionally, we caution readers that the list of risk factors discussed in our SEC filings may not contain all of the material factors that are important to you. In addition, in light of these risks and uncertainties, the matters referred to in the forward-looking statements contained in this report may not in fact occur. Accordingly, readers should not place undue reliance on those statements.
We are exposed to various risks due to economic, political and social instabilities, market volatility, natural disasters, debt and credit issues, currency controls, new or increased tariffs, foreign exchange and interest rate changes. These risks can negatively impact our net sales, net earnings and cash flows.
- 18 -
Item 6. Exhibits
The following exhibits are filed or furnished herewith or incorporated by reference as indicated.
|
Incorporated by reference to
|
||
|
31.1*
|
Rule 13a-14(a)/15d-14(a) Certification of the Chief Executive Officer.
|
|
|
31.2*
|
Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer.
|
|
|
32.1**
|
Section 1350 Certification of the Chief Executive Officer.
|
|
|
32.2**
|
Section 1350 Certification of the Chief Financial Officer.
|
|
|
101.INS
|
Inline XBRL Instance Document – the instance document does not appear in the Interactive Data file because its iXBRL tags are embedded within the Inline XBRL document.
|
|
|
101.SCH
|
Inline XBRL Taxonomy Extension Schema.
|
|
|
101.CAL
|
Inline XBRL Extension Calculation Linkbase.
|
|
|
101.DEF
|
Inline XBRL Extension Definition Linkbase.
|
|
|
101.LAB
|
Inline XBRL Extension Label Linkbase.
|
|
|
101.PRE
|
Inline XBRL Extension Presentation Linkbase.
|
|
|
104
|
Cover Page Interactive Data File (formatted as an inline XBRL and contained in Exhibit 101).
|
* Filed herewith
** Furnished herewith
- 19 -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
Magnera Corporation
|
||
|
|
|
|
|
|
August 6, 2025
|
By:
|
|
/s/ James M. Till
|
|
|
|
|
James M. Till
|
|
|
|
|
Chief Financial Officer
|
- 20 -
Magnera
NYSE:MAGN
MAGN Rankings
MAGN Latest News
MAGN Latest SEC Filings
Aug 8, 2025
[SCHEDULE 13G/A] Magnera Corporation SEC Filing
Aug 6, 2025
[8-K] Magnera Corporation Reports Material Event
Aug 6, 2025
[SCHEDULE 13G] Magnera Corporation SEC Filing
Jul 29, 2025
[SCHEDULE 13G/A] Magnera Corporation SEC Filing